522
Views
23
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate

, &
Pages 1679-1686 | Received 20 Jul 2016, Accepted 12 Oct 2016, Published online: 02 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pasquale De Franciscis, Antonio Schiattarella, Gaetano Riemma, Domenico Labriola, Domenico Ambrosio, Salvatore Giovanni Vitale, Antonio Cianci, Gaspare Cucinella, Gloria Calagna & Nicola Colacurci. (2022) Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study. Minimally Invasive Therapy & Allied Technologies 31:3, pages 435-440.
Read now
Manuela Farris, Carlo Bastianelli, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2019) Uterine fibroids: an update on current and emerging medical treatment options. Therapeutics and Clinical Risk Management 15, pages 157-178.
Read now
Francesca Conway, Giulia Morosetti, Sara Camilli, Francesco Giuseppe Martire, Giuseppe Sorrenti, Emilio Piccione, Errico Zupi & Caterina Exacoustos. (2019) Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids. Gynecological Endocrinology 35:3, pages 207-210.
Read now

Articles from other publishers (20)

Anita L. Nelson. 2020. Handbook of Gynecology. Handbook of Gynecology 1 22 .
Anita L. Nelson. 2023. Handbook of Gynecology. Handbook of Gynecology 261 282 .
Manuel Gonçalves-Henriques, António de Pinho, Marília Freixo, Maria Liz-Coelho, Fabiana Castro, Nathan Ceschin & Pedro Brandão. (2022) Ulipristal acetate in adenomyosis. Gynecology and Minimally Invasive Therapy 0:0, pages 0.
Crossref
Veladanda Kavitha & Rachamalla Madhuri. (2021) Ulipristal Acetate Versus Leuprolide Acetate in Medical Management of Uterine Fibroids. Journal of Evolution of Medical and Dental Sciences 10:43, pages 3701-3706.
Crossref
Jacques Donnez & Marie-Madeleine Dolmans. (2020) Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review. Reproductive BioMedicine Online 41:3, pages 431-442.
Crossref
Olivier Donnez & Jacques Donnez. (2020) Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis. Fertility and Sterility 114:3, pages 640-645.
Crossref
Andrea Tinelli, Ioannis P. Kosmas, Ospan A. Mynbaev, Antonio Malvasi, Radmila Sparic & Daniele Vergara. (2020) The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth. Current Pharmaceutical Design 26:3, pages 310-317.
Crossref
Thomas Römer. (2019) Ulipristalacetat – aktueller Stellenwert in der MyombehandlungUlipristal acetate—current importance in myoma treatment. Gynäkologische Endokrinologie 18:1, pages 35-42.
Crossref
Iwona Szydłowska, Aleksandra Marciniak, Jolanta Nawrocka-Rutkowska, Aleksandra Rył & Andrzej Starczewski. (2020) Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids. International Journal of Environmental Research and Public Health 17:3, pages 798.
Crossref
Marie‐Madeleine Dolmans, Jacques Donnez & Latifa Fellah. (2019) Uterine fibroid management: Today and tomorrow. Journal of Obstetrics and Gynaecology Research 45:7, pages 1222-1229.
Crossref
Annalisa Di Cello, Massimo Borelli, Maria Luisa Marra, Marco Franzon, Pietro D’Alessandro, Costantino Di Carlo, Roberta Venturella & Fulvio Zullo. (2019) A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes’ results in patients with uterine masses. European Journal of Obstetrics & Gynecology and Reproductive Biology 236, pages 143-147.
Crossref
C. Berger, N. Boggavarapu, E. Norlin, S. Queckbörner, K. Hörnaeus, A. Falk, M. Engman, M. Ramström, P.G.L. Lalitkumar & K. Gemzell-Danielsson. (2018) Molecular characterization of PRM-associated endometrial changes, PAEC, following mifepristone treatment. Contraception 98:4, pages 317-322.
Crossref
Jacques Donnez, Guillaume E. Courtoy, Olivier Donnez & Marie-Madeleine Dolmans. (2018) Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review. Reproductive BioMedicine Online 37:2, pages 216-223.
Crossref
Jorge E. Shortrede, Maria M. Montt-Guevara, Gisela Pennacchio, Michele Finiguerra, Andrea Giannini, Alessandro D. Genazzani & Tommaso Simoncini. (2018) Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells. Frontiers in Endocrinology 9.
Crossref
James A. Simon, William Catherino, James H. Segars, Rick E. Blakesley, Anna Chan, Vilma Sniukiene & Ayman Al-Hendy. (2018) Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas. Obstetrics & Gynecology 131:3, pages 431-439.
Crossref
Barbara Schütt, Marcus-Hillert Schultze-Mosgau, Corinna Draeger, Xinying Chang, Stephanie Löwen, Andreas Kaiser & Beate Rohde. (2018) Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women. The Journal of Clinical Pharmacology 58:2, pages 228-239.
Crossref
Kim E Kortekaas & Harold M P Pelikan. (2018) Non-surgical intervention for retroperitoneal lymphogenic and pulmonary metastases of a benign leiomyoma: treatment with ulipristal acetate. BMJ Case Reports, pages bcr-2017-222693.
Crossref
Michał Ciebiera, Krzysztof Łukaszuk, Błażej Męczekalski, Magdalena Ciebiera, Cezary Wojtyła, Aneta Słabuszewska-Jóźwiak & Grzegorz Jakiel. (2017) Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids—An Up-to-Date Review. International Journal of Molecular Sciences 18:12, pages 2586.
Crossref
T. Römer. (2017) Uterus myomatosus und InfertilitätUterine fibroids and infertility. Gynäkologische Endokrinologie 15:4, pages 266-272.
Crossref
P. Kadhel, M. Smail & D. Borja De Mozota. (2017) Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma. Journal of Gynecology Obstetrics and Human Reproduction 46:7, pages 609-611.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.